First and Second Generation DES Reduce Diabetes Adverse Effect on Mortality and Re-intervention in Multivessel Coronary Disease: 9-Year Analysis

Abstract Background/Purpose Diabetes portends an increased risk of adverse early and late outcomes in patients undergoing PCI. In this study, we aimed to investigate if the adverse effect of Diabetes Mellitus ( DM ) on early and late PCI outcomes is reduced with drug-eluting ( DES ) compared to bare-metal ( BMS ) stents. Methods/Materials We reviewed the Mount Sinai Beth Israel Hospital first PCI experience for multivessel coronary artery disease ( CAD , 1998–2009). Patients were excluded if single-vessel CAD, emergency, no stent, prior bypass graft or myocardial infarction